Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-10-05 00:00:00 ET · period of report 2022-10-03 · accession 0001765581-22-000116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-05 | 2022-10-03 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale+OE | $134.93 | -45.2K | 405.4K | -10% | -$6.10M |
| D | 2022-10-05 | 2022-10-03 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $59.13 | +62.9K | 419.2K | +18% | +$3.72M |
| D | 2022-10-05 | 2022-10-03 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $0.00 | -62.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-10-03 | S | D | 7,748 | $135.80 | 374,028 | D | — | — | (F4) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.57 to $136.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 2 | Common | Ordinary Shares | 2022-10-03 | S | D | 23,646 | $135.18 | 381,776 | D | — | — | (F3) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $134.57 to $135.56. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 3 | Common | Ordinary Shares | 2022-10-03 | S | D | 13,791 | $134.02 | 405,422 | D | — | — | (F2) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $133.56 to $134.54. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 4 | Common | Ordinary Shares | 2022-10-03 | M | A | 62,905 | $59.13 | 419,213 | D | — | — | |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-10-03 | M | D | 62,905 | $0.00 | 0 | D | $59.13 · — to 2023-03-04 | 62,905 Ordinary Shares | (F6) This non-qualified stock option is part of an option granted on March 5, 2013. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017. |